Ningning Yan Siyuan Huang Linlin Li Qianqian Guo Di Geng Huixian Zhang Sanxing Guo Xingya Li
10.3389/fphar.2022.898623
Front Pharmacol
2022 Sep 9;13:898623.
nsclc ros1 chemo-immunotherapy immune checkpoint inhibitor lung adenocarcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/36160430/
Case Reports
PMC9500430
36160430
Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report
2022